The current landscape for hepatitis C treament in Australia is very different from that in the US and some other countries. We don’t have access to the latest direct acting antivirals (DAA) and the last drug approved by the Pharmaceutical Benefits Scheme (PBS) was webinar that leads Australians through the changing treatment landscape. Prof Greg Dore is an expert in this field and an outspoken advocate for the hep C community. If you haven’t seen it yet, Australians, watch it.
Finally, you are your best advocate. This is your health.
Go out there and bat for yourself. You deserve it.
(Thanks to Mousey, a fellow Australian hep C traveller whose preparation for new treatment options prompted this post)